查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
鴉片類藥物市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、應用、給藥途徑、配銷通路和地理位置
市場調查報告書
商品編碼
1482328

鴉片類藥物市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、應用、給藥途徑、配銷通路和地理位置

Opioids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, Route Of Administration, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 209 Pages | 訂單完成後即時交付

價格

鴉片類藥物市場預計將從 2023 年的 129.3 億美元成長到 2031 年的 150.3 億美元；預計2023年至2031年複合年成長率為1.9%。

鴉片類藥物是一類廣泛的藥物，主要用於緩解疼痛。這些藥物非常有效，但也可能導致成癮。鴉片類藥物透過作用於大腦受體發揮作用，從而提供多種效果，包括緩解疼痛。鴉片類藥物包括海洛因、嗎啡、可待因、芬太尼、美沙酮、曲馬多和其他類似物質。鴉片類藥物市場規模的不斷成長歸因於全球慢性疼痛發病率的激增。此外，世界各地老年人口的增加也推動了鴉片類藥物市場的成長。專注於開發預防和治療鴉片類藥物過量和疾病的藥物的政府舉措可能會在預測期內帶來新的鴉片類藥物市場趨勢。

市場參與者的策略性舉措將為鴉片類藥物市場成長創造機會。

鴉片類藥物市場參與者投資研發活動，以確保開發有效的產品。 2023年5月，Indivior PLC獲得美國食品藥物管理局（FDA）核准OPVEE（納美芬）鼻噴劑緊急用於治療成人及12歲以上兒童患者因合成或天然鴉片類藥物引起的疑似或已知鴉片類藥物過量，其特徵是中樞神經系統和/或呼吸抑制。此外，2021年12月，山德士宣佈在美國推出學名藥Narcan（鹽酸納洛酮）鼻噴劑4mg；該產品用於逆轉鴉片類藥物過量。美國的個人可以立即透過零售藥局和機構（包括醫院）獲得納洛酮。最後，2023 年 8 月，Emergent BioSolutions 推出了非處方 NARCAN 鼻噴劑，使每個人都可以在鴉片類藥物過量緊急情況下幫助挽救生命。因此，戰略舉措可能會在未來幾年為鴉片類藥物市場提供成長機會。

根據地理位置，鴉片類藥物市場分為北美（美國、加拿大和墨西哥）、歐洲（英國、德國、法國、義大利、西班牙、俄羅斯和歐洲其他地區）、亞太地區（中國、日本、印度、韓國、澳大利亞、東南亞和亞太地區其他地區）、中東和非洲（阿拉伯聯合大公國、沙烏地阿拉伯、南非以及中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和其他地區）南美洲和中美洲）。由於生活方式因素，2023 年北美在全球鴉片類藥物市場中佔據最大佔有率。然而，預計亞太地區 2023 年至 2031 年複合年成長率最高。 2022年，美國在北美鴉片類藥物市場中佔據最大佔有率。例如，2024年，Hikma Pharmaceuticals PLC推出了檸檬酸芬太尼注射（USP），劑量為25mcg/0.5mL和50mcg/mL。 Hikma 向美國市場推出了首款 FDA 批准的 25mcg/0.5mL 包裝。該公司預計將透過推出擴大其產品組合，擴大醫院可用藥物的選擇。此外，Rusan Pharma 於 2023 年在印度中央邦推出了最先進的 API 設施。該設施的設計符合嚴格的國際監管準則，確保最高水準的合規性。具備年產400噸原料藥的生產能力。此次設施擴建將確保關鍵原料藥的供應安全，以滿足印度和全球對成癮治療和疼痛管理產品不斷成長的需求。此外，2023年，Neuraxpharm宣布完成從賽諾菲收購兩個針對中樞神經系統疾病、疼痛和血管疾病的成熟產品組合。 Neuraxpharm 收購的成熟產品包括15 種針對中樞神經系統疾病的產品以及兩種針對疼痛和血管疾病的產品。疾病的產品組合。 BDSI 的商業成長驅動力 BELBUCA 是一種具有顯著差異化的 III 號鴉片類藥物產品，與 Collegium 的疼痛產品組合高度互補。因此，上述因素支撐了市場的成長。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：鴉片類藥物市場格局

  • 概述
  • PEST分析

第 5 章：鴉片類藥物市場 - 主要市場動態

  • 鴉片類藥物市場 - 主要市場動態
  • 市場促進因素
    • 慢性疼痛發生率激增
    • 老年人口增加
  • 市場限制
    • 藥物濫用增加
  • 市場機會
    • 市場參與者的策略性舉措
  • 未來的趨勢
    • 政府措施重點關注開發預防和治療鴉片類藥物過量和疾病的藥物
  • 促進因素和限制的影響：

第 6 章：鴉片類藥物市場 - 全球市場分析

  • 鴉片類藥物市場收入，2022-2030
  • 鴉片類藥物市場預測分析

第 7 章：鴉片類藥物市場分析 - 按產品

  • 速釋短效鴉片類藥物
  • 緩釋長效型鴉片類藥物

第 8 章：鴉片類藥物市場分析 - 按應用

  • 疼痛管理
  • 麻醉
  • 抑制腹瀉
  • 止咳
  • 戒癮
  • 其他

第 9 章：鴉片類藥物市場分析 - 按給藥途徑

  • 口服
  • 可注射
  • 經皮貼劑

第 10 章：鴉片類藥物市場分析 - 按配銷通路

  • 醫院藥房
  • 零售藥局

第 11 章：鴉片類藥物市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：產業格局

  • 概述
  • 鴉片類藥物市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Purdue Pharma LP
  • Endo International plc
  • Mallinckrodt Plc
  • Collegium Pharmaceutical Inc
  • Neuraxpharm Pharmaceuticals SL
  • Hikma Pharmaceuticals Plc
  • Mayne Pharma Group Ltd
  • Rusan Pharma Ltd
  • Trevena Inc
  • Teva Pharmaceutical Industries Ltd

第 14 章：附錄

Product Code: TIPRE00004770

The Opioids market is expected to grow from US$ 12.93 billion in 2023 to US$ 15.03 billion by 2031; it is anticipated to record a CAGR of 1.9% from 2023 to 2031.

Opioids are a broad group of medicines majorly used for relieving pain. These medicines are highly effective but can also leads to an addiction. Opioid acts by working on brain receptors and thus provide the varieties of effect including the pain relief. Opioid includes heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances. The growing opioids market size is attributed to the surging chronic pain incidences across the world. In addition, the increasing geriatric population across the world are fueling opioid market growth. A government initiative focusing on the development of medication to prevent and treat opioid overdose and disorders is likely to bring new opioids market trends during the forecast period.

Strategic Initiatives by Market Players will Create an Opportunity for Opioid market growth.

Opioids market players invest in R&D activities to ensure the development of effective products. In May 2023, Indivior PLC received the US Food and Drug Administration (FDA) approval for OPVEE (nalmefene) nasal spray for emergency use to treat suspected or known opioid overdose induced by synthetic or natural opioids in adults and pediatric patients aged 12 years and more, which is characterized by CNS and/or respiratory depression. Further, in December 2021, Sandoz announced the launch of its generic Narcan (naloxone hydrochloride) Nasal Spray 4mg in the US; the product is used to reverse opioid overdose. Individuals in the US can immediately obtain Narcan via retail pharmacies and institutions, including hospitals. Lastly, in August 2023, Emergent BioSolutions launched the over-the-counter NARCAN Nasal Spray, making it possible for everybody to help save a life from an opioid overdose emergency. Therefore, strategic initiatives are likely to offer growth opportunities to the opioids market in the coming years.

Based on geography, the Opioid market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). North America held the largest share of the global Opioid market in 2023 owing to the lifestyle factor. However, Asia Pacific is predicted to register the highest CAGR during 2023-2031. The US held the largest share of the Opioid market in North America in 2022. US market players are adopting organic and inorganic strategies for Opioid market development. For instance, in 2024, Hikma Pharmaceuticals PLC launched Fentanyl Citrate Injection, USP, in 25mcg/0.5mL and 50mcg/mL doses. Hikma introduced the first FDA approved 25mcg/0.5mL presentation to the US market. The company is expected to expand its portfolio with the launch, broadening the choice of medicines available to hospitals. Furthermore, in 2023, Rusan Pharma launched its state-of-the-art API facility in Madhya Pradesh, India. The facility is designed to meet stringent international regulatory guidelines, ensuring the highest level of compliance. With the production capability of 400 metric tons of APIs annually. This facility expansion will ensure the security of supply of critical APIs to meet the growing demand for addiction treatment and pain management products in India and globally. Moreover in 2023, Neuraxpharm announced the closing of the acquisition of two established product portfolios for CNS disorders, pain and vascular diseases from Sanofi. The well-established products that Neuraxpharm acquired includes 15 products addressing CNS disorders and two products in pain and vascular diseases, and in 2022, Collegium Pharmaceutical, Inc. announced that it completed the acquisition of BioDelivery Sciences International Inc. BDSI has a portfolio of pain and neurology products that address serious and debilitating conditions. BDSI's commercial growth driver, BELBUCA, is a meaningfully differentiated schedule III opioid product and is highly complementary to Collegium's portfolio of pain products. Thus, the factors mentioned above support the market growth.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Opioids Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Opioids Market - Key Market Dynamics

  • 5.1 Opioids Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Surging Chronic Pain Incidence
    • 5.2.2 Increasing Geriatric Population
  • 5.3 Market Restraints
    • 5.3.1 Increasing Drug Abuse
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Government Initiatives Focusing on Development of Medication to Prevent and Treat Opioid Overdose and Disorder
  • 5.6 Impact of Drivers and Restraints:

6. Opioids Market - Global Market Analysis

  • 6.1 Opioids Market Revenue (US$ Million), 2022-2030
  • 6.2 Opioids Market Forecast Analysis

7. Opioids Market Analysis - by Product

  • 7.1 Immediate Release Short Acting Opioid
    • 7.1.1 Overview
    • 7.1.2 Immediate Release Short Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.1 Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • 7.2 Extended Release Long-Acting Opioid
    • 7.2.1 Overview
    • 7.2.2 Extended Release Long-Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.1 Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

8. Opioids Market Analysis - by Application

  • 8.1 Pain Management
    • 8.1.1 Overview
    • 8.1.2 Pain Management: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Anesthesia
    • 8.2.1 Overview
    • 8.2.2 Anesthesia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Diarrhoea Suppression
    • 8.3.1 Overview
    • 8.3.2 Diarrhoea Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cough Suppression
    • 8.4.1 Overview
    • 8.4.2 Cough Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 De-Addiction
    • 8.5.1 Overview
    • 8.5.2 De-Addiction: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. Opioids Market Analysis - by Route of Administration

  • 9.1 Oral
    • 9.1.1 Overview
    • 9.1.2 Oral: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Injectable
    • 9.2.1 Overview
    • 9.2.2 Injectable: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Transdermal Patch
    • 9.3.1 Overview
    • 9.3.2 Transdermal Patch: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. Opioids Market Analysis - by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Overview
    • 10.1.2 Hospital Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Retail Pharmacies
    • 10.2.1 Overview
    • 10.2.2 Retail Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

11. Opioids Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Opioids Market Overview
    • 11.2.2 North America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.2.2.1 North America: Opioids Market - Revenue and Forecast Analysis - by Product
    • 11.2.3 North America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
      • 11.2.3.1 North America: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.2.3.2 North America: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
      • 11.2.3.3 North America: Opioids Market - Revenue and Forecast Analysis - by Application
    • 11.2.4 North America: Opioids Market Breakdown, by Route of Administration
      • 11.2.4.1 North America: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
      • 11.2.4.2 North America: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.2.5 North America: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.2.5.1 North America: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.2.5.2 United States: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.5.2.1 United States: Opioids Market Breakdown, by Product
        • 11.2.5.2.2 United States: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.2.5.2.3 United States: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.2.5.2.4 United States: Opioids Market Breakdown, by Application
        • 11.2.5.2.5 United States: Opioids Market Breakdown, by Route of Administration
        • 11.2.5.2.6 United States: Opioids Market Breakdown, by Distribution Channel
      • 11.2.5.3 Canada: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.5.3.1 Canada: Opioids Market Breakdown, by Product
        • 11.2.5.3.2 Canada: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.2.5.3.3 Canada: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.2.5.3.4 Canada: Opioids Market Breakdown, by Application
        • 11.2.5.3.5 Canada: Opioids Market Breakdown, by Route of Administration
        • 11.2.5.3.6 Canada: Opioids Market Breakdown, by Distribution Channel
      • 11.2.5.4 Mexico: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.5.4.1 Mexico: Opioids Market Breakdown, by Product
        • 11.2.5.4.2 Mexico: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.2.5.4.3 Mexico: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.2.5.4.4 Mexico: Opioids Market Breakdown, by Application
        • 11.2.5.4.5 Mexico: Opioids Market Breakdown, by Route of Administration
        • 11.2.5.4.6 Mexico: Opioids Market Breakdown, by Distribution Channel
  • 11.3 Europe
    • 11.3.1 Europe Opioids Market Overview
    • 11.3.2 Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Europe: Opioids Market Breakdown, by Product
      • 11.3.3.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Product
      • 11.3.3.2 Europe: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.3.3.3 Europe: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
      • 11.3.3.4 Europe: Opioids Market - Revenue and Forecast Analysis - by Application
      • 11.3.3.5 Europe: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
      • 11.3.3.6 Europe: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.3.4 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.3.4.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.3.4.2 United Kingdom: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.2.1 United Kingdom: Opioids Market Breakdown, by Product
        • 11.3.4.2.2 United Kingdom: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.2.3 United Kingdom: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.2.4 United Kingdom: Opioids Market Breakdown, by Application
        • 11.3.4.2.5 United Kingdom: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.2.6 United Kingdom: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.3 Germany: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.3.1 Germany: Opioids Market Breakdown, by Product
        • 11.3.4.3.2 Germany: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.3.3 Germany: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.3.4 Germany: Opioids Market Breakdown, by Application
        • 11.3.4.3.5 Germany: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.3.6 Germany: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.4 France: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.4.1 France: Opioids Market Breakdown, by Product
        • 11.3.4.4.2 France: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.4.3 France: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.4.4 France: Opioids Market Breakdown, by Application
        • 11.3.4.4.5 France: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.4.6 France: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.5 Italy: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.5.1 Italy: Opioids Market Breakdown, by Product
        • 11.3.4.5.2 Italy: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.5.3 Italy: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.5.4 Italy: Opioids Market Breakdown, by Application
        • 11.3.4.5.5 Italy: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.5.6 Italy: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.6 Spain: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.6.1 Spain: Opioids Market Breakdown, by Product
        • 11.3.4.6.2 Spain: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.6.3 Spain: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.6.4 Spain: Opioids Market Breakdown, by Application
        • 11.3.4.6.5 Spain: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.6.6 Spain: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.7.1 Rest of Europe: Opioids Market Breakdown, by Product
        • 11.3.4.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.7.4 Rest of Europe: Opioids Market Breakdown, by Application
        • 11.3.4.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Opioids Market Overview
    • 11.4.2 Asia Pacific: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.4.2.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Product
      • 11.4.2.2 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.4.2.3 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
      • 11.4.2.4 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Application
      • 11.4.2.5 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
      • 11.4.2.6 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.4.3 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.2 China: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.2.1 China: Opioids Market Breakdown, by Product
        • 11.4.3.2.2 China: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.2.3 China: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.2.4 China: Opioids Market Breakdown, by Application
        • 11.4.3.2.5 China: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.2.6 China: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.3 Japan: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.3.1 Japan: Opioids Market Breakdown, by Product
        • 11.4.3.3.2 Japan: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.3.3 Japan: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.3.4 Japan: Opioids Market Breakdown, by Application
        • 11.4.3.3.5 Japan: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.3.6 Japan: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.4 India: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.4.1 India: Opioids Market Breakdown, by Product
        • 11.4.3.4.2 India: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.4.3 India: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.4.4 India: Opioids Market Breakdown, by Application
        • 11.4.3.4.5 India: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.4.6 India: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.5 South Korea: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.5.1 South Korea: Opioids Market Breakdown, by Product
        • 11.4.3.5.2 South Korea: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.5.3 South Korea: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.5.4 South Korea: Opioids Market Breakdown, by Application
        • 11.4.3.5.5 South Korea: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.5.6 South Korea: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.6 Australia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.6.1 Australia: Opioids Market Breakdown, by Product
        • 11.4.3.6.2 Australia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.6.3 Australia: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.6.4 Australia: Opioids Market Breakdown, by Application
        • 11.4.3.6.5 Australia: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.6.6 Australia: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.7 Rest of APAC: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.7.1 Rest of APAC: Opioids Market Breakdown, by Product
        • 11.4.3.7.2 Rest of APAC: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.7.3 Rest of APAC: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.7.4 Rest of APAC: Opioids Market Breakdown, by Application
        • 11.4.3.7.5 Rest of APAC: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.7.6 Rest of APAC: Opioids Market Breakdown, by Distribution Channel
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Opioids Market Overview
    • 11.5.2 Middle East and Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.5.2.1 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Product
      • 11.5.2.2 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.5.2.3 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
      • 11.5.2.4 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Application
      • 11.5.2.5 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
      • 11.5.2.6 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
      • 11.5.2.7 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.5.2.8 Saudi Arabia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.2.8.1 Saudi Arabia: Opioids Market Breakdown, by Product
        • 11.5.2.8.2 Saudi Arabia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.5.2.8.3 Saudi Arabia: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.5.2.8.4 Saudi Arabia: Opioids Market Breakdown, by Application
        • 11.5.2.8.5 Saudi Arabia: Opioids Market Breakdown, by Route Of Administration
        • 11.5.2.8.6 Saudi Arabia: Opioids Market Breakdown, by Distribution Channel
      • 11.5.2.9 South Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.2.9.1 South Africa: Opioids Market Breakdown, by Product
        • 11.5.2.9.2 South Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.5.2.9.3 South Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.5.2.9.4 South Africa: Opioids Market Breakdown, by Application
        • 11.5.2.9.5 South Africa: Opioids Market Breakdown, by Route Of Administration
        • 11.5.2.9.6 South Africa: Opioids Market Breakdown, by Distribution Channel
      • 11.5.2.10 United Arab Emirates: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.2.10.1 United Arab Emirates: Opioids Market Breakdown, by Product
        • 11.5.2.10.2 United Arab Emirates: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.5.2.10.3 United Arab Emirates: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.5.2.10.4 United Arab Emirates: Opioids Market Breakdown, by Application
        • 11.5.2.10.5 United Arab Emirates: Opioids Market Breakdown, by Route Of Administration
        • 11.5.2.10.6 United Arab Emirates: Opioids Market Breakdown, by Distribution Channel
      • 11.5.2.11 Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.2.11.1 Rest of Middle East and Africa: Opioids Market Breakdown, by Product
        • 11.5.2.11.2 Rest of Middle East and Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.5.2.11.3 Rest of Middle East and Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.5.2.11.4 Rest of Middle East and Africa: Opioids Market Breakdown, by Application
        • 11.5.2.11.5 Rest of Middle East and Africa: Opioids Market Breakdown, by Route Of Administration
        • 11.5.2.11.6 Rest of Middle East and Africa: Opioids Market Breakdown, by Distribution Channel
  • 11.6 South and Central America
    • 11.6.1 South and Central America Opioids Market Overview
    • 11.6.2 South and Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.6.2.1 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Product
      • 11.6.2.2 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.6.2.3 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long Acting Opioid
      • 11.6.2.4 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Application
      • 11.6.2.5 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Route Of Administration
      • 11.6.2.6 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.6.3 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.6.3.1 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.6.3.2 Brazil: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.2.1 Brazil: Opioids Market Breakdown, by Product
        • 11.6.3.2.2 Brazil: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.6.3.2.3 Brazil: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.6.3.2.4 Brazil: Opioids Market Breakdown, by Application
        • 11.6.3.2.5 Brazil: Opioids Market Breakdown, by Route Of Administration
        • 11.6.3.2.6 Brazil: Opioids Market Breakdown, by Distribution Channel
      • 11.6.3.3 Argentina: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.3.1 Argentina: Opioids Market Breakdown, by Product
        • 11.6.3.3.2 Argentina: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.6.3.3.3 Argentina: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.6.3.3.4 Argentina: Opioids Market Breakdown, by Application
        • 11.6.3.3.5 Argentina: Opioids Market Breakdown, by Route Of Administration
        • 11.6.3.3.6 Argentina: Opioids Market Breakdown, by Distribution Channel
      • 11.6.3.4 Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.4.1 Rest of South and Central America: Opioids Market Breakdown, by Product
        • 11.6.3.4.2 Rest of South and Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.6.3.4.3 Rest of South and Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.6.3.4.4 Rest of South and Central America: Opioids Market Breakdown, by Application
        • 11.6.3.4.5 Rest of South and Central America: Opioids Market Breakdown, by Route Of Administration
        • 11.6.3.4.6 Rest of South and Central America: Opioids Market Breakdown, by Distribution Channel

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Opioids Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Purdue Pharma LP
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Endo International plc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Mallinckrodt Plc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Collegium Pharmaceutical Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Neuraxpharm Pharmaceuticals SL
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Hikma Pharmaceuticals Plc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Mayne Pharma Group Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Rusan Pharma Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Trevena Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Teva Pharmaceutical Industries Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Opioids Market Segmentation
  • Table 2. Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 5. Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 6. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 7. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 8. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 9. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 10. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 11. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 12. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 13. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 14. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 15. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 16. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 17. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 18. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 19. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 20. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 21. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 22. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 23. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 24. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 25. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 26. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 27. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 28. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 30. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 31. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 32. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 33. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 34. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 35. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 36. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 37. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 38. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 39. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 40. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 41. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 42. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 43. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 44. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 45. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 46. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 47. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 48. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 49. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 50. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 51. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 52. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 53. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 54. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 55. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 56. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 57. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 58. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 59. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 60. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 61. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 62. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 63. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 64. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 65. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 66. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 67. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 68. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 69. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 70. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 71. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 72. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 73. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 74. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 75. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 76. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 77. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 78. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 79. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 80. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 81. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 82. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 83. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 84. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 85. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 86. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 87. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 88. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 89. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 90. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 91. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 92. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 93. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 94. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 95. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 96. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 97. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 98. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 99. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 100. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 101. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 102. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 103. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 104. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 105. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 106. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 107. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 108. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 109. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 110. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 111. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 112. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 113. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 114. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 115. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 116. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 117. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 118. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 119. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 120. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 121. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 122. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 123. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 124. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 125. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 126. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 127. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 128. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 129. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 130. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 131. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 132. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 133. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 134. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 135. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 136. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 137. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 138. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 139. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 140. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 141. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 142. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 143. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 144. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 145. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 146. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 147. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 148. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 149. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 150. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 151. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 152. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 153. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 154. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 155. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 156. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 157. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 158. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 159. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 160. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 161. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 162. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 163. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 164. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 165. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 166. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 167. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 168. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 169. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 170. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 171. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 172. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 173. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 174. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 175. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 176. Recent Organic Growth Strategies in Opioids Market
  • Table 177. Recent Inorganic Growth Strategies in the Opioids Market
  • Table 178. Glossary of Terms, Opioids Market

List Of Figures

  • Figure 1. Opioids Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Opioids Market Revenue (US$ Million), 2022-2030
  • Figure 5. Opioids Market Breakdown by Geography, 2022 and 2030 (%)
  • Figure 6. Opioids Market Share (%) - by Product (2022 and 2030)
  • Figure 7. Immediate Release Short Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Extended Release Long-Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Opioids Market Share (%) - by Application (2022 and 2030)
  • Figure 10. Pain Management: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Anesthesia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Diarrhoea Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cough Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. De-Addiction: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Opioids Market Share (%) - by Route of Administration (2022 and 2030)
  • Figure 17. Oral: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Injectable: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Transdermal Patch: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 21. Hospital Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Opioids Market Breakdown by Region, 2022 and 2030 (%)
  • Figure 24. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 25. North America: Opioids Market Breakdown, by Route of Administration (2022 and 2030)
  • Figure 26. North America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 32. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. France: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 40. China: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 41. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 42. India: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 43. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 44. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 45. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 46. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 47. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 48. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 49. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 50. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 51. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 52. South and Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 53. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 54. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 55. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 56. Growth Strategies in Opioids Market